W. . Disphanurat and B. . Srisantithum, “Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial”, AMJAM, vol. 22, no. -, p. S117, Aug. 2022.